| Today's Open | $1.60 |
|---|---|
| Previous Close | $1.62 |
| Daily Range | $1.57 - $1.68 |
| 52-Week Range | $1.50 - $3.51 |
| Market Cap | $86.8M |
| P/E Ratio | -1.86 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 427,876 |
| Average Daily Volume | 601,216 |
| Current FY EPS | -$1.05 |
Sector
Healthcare
Industry
Drugs
Discovery Laboratories, Inc. (DSCO) Description
A biotechnology company, which develops its proprietary surfactant technology as Surfactant Replacement Therapies for respiratory disorders and diseases. Website: http://www.discoverylabs.com/
News & Commentary
Discovery Labs to Float Stock Issue
The company aims to raise net proceeds of more than $13 million in the issue.The FDA Issues a Stunning Rejection
Gilead receives a complete response letter for part of an already approved drug.Discovering Yet Another Drug Delay
This company is king when it comes to drug delays.Market Close: Big Winners & Losers for April 15, 2013 (GENE, THRX, SGRP, MAGS, CNIT, UNTK, GSS, DSCO
Market Close: Big Winners & Losers for April 15, 2013 (GENE, THRX, SGRP, MAGS, CNIT, UNTK, GSS, DSCO, HXM, ECTY)DSCO's Top Competitors
(0.62%)
(-0.67%)
(-1.07%)
(-0.14%)